Chitosan and aloe vera-based biomaterials for wound healing applications

Abstract The complexity of wound healing, particularly for chronic wounds, necessitates advanced dressings that actively modulate the wound microenvironment. This work critically evaluates the synergistic integration of chitosan (CS) and aloe vera (AV) into advanced wound dressings. Chitosan offers a biocompatible, biodegradable, antimicrobial, and hemostatic scaffold, while Aloe vera contributes potent anti-inflammatory, antioxidant, moisturizing, and pro-regenerative biomaterials. While single-component products based on CS (e.g., MaxioCel®) or AV (e.g., Acemannan hydrogel) are clinically established, hybrid CS–AV systems present distinct synergistic advantages across multiple phases of tissue repair. The review details innovative formulations, including hydrogels, nanofibers, 3D-printed structures, films, and sponges, highlighting advancements in crosslinking, functional additives (e.g., antimicrobials, growth factors), and fabrication techniques. Mechanistically, CS-AV synergy manifests through enhanced antimicrobial efficacy, potent anti-inflammatory and antioxidant effects via modulation of cytokine profiles and ROS scavenging, stimulation of cellular proliferation and migration (fibroblasts, keratinocytes), and positive influence on extracellular matrix (ECM) remodeling, potentially leading to reduced scar formation. Preclinical evidence consistently demonstrates accelerated wound closure, improved re-epithelialization, enhanced angiogenesis, and superior tissue quality in various animal models. However, substantial translational challenges remain regarding raw material standardization (CS molecular weight/deacetylation degree and AV acemannan quantification), residual crosslinker safety, and a lack of randomized clinical trials. This review critically balances the promising preclinical efficacy of CS–AV composites with the rigorous standardization, GLP toxicological profiling, and clinical frameworks required for bench-to-bedside translation.

Authors

Institutions

Publication Details

Journal
Discover Materials
Published
2026-11-01
DOI
https://doi.org/10.1007/s43939-026-01064-w
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chitosan and aloe vera-based biomaterials for wound healing applications

Yasser Fakri Mustafa, Abdullah Ali Alzahrani, Maher Abdulrazzaq Al-hakeem, Mohammad Ehsan Taghavizadeh Yazdi et al.
5 links
Discover Materials
Wound Healing and Treatments
article

Chitosan and aloe vera-based biomaterials for wound healing applications

Yasser Fakri Mustafa, Abdullah Ali Alzahrani, Maher Abdulrazzaq Al-hakeem, Mohammad Ehsan Taghavizadeh Yazdi, Shakeel Ahmed Ansari, Zahir Al-Khafaji, Zainab Sadeq Yousif, Jawad Mahmood, Shahabe Saquib Abullais, Yasir Qasim Almajidi
article en

Abstract

Abstract The complexity of wound healing, particularly for chronic wounds, necessitates advanced dressings that actively modulate the wound microenvironment. This work critically evaluates the synergistic integration of chitosan (CS) and aloe vera (AV) into advanced wound dressings. Chitosan offers a biocompatible, biodegradable, antimicrobial, and hemostatic scaffold, while Aloe vera contributes potent anti-inflammatory, antioxidant, moisturizing, and pro-regenerative biomaterials. While single-component products based on CS (e.g., MaxioCel®) or AV (e.g., Acemannan hydrogel) are clinically established, hybrid CS–AV systems present distinct synergistic advantages across multiple phases of tissue repair. The review details innovative formulations, including hydrogels, nanofibers, 3D-printed structures, films, and sponges, highlighting advancements in crosslinking, functional additives (e.g., antimicrobials, growth factors), and fabrication techniques. Mechanistically, CS-AV synergy manifests through enhanced antimicrobial efficacy, potent anti-inflammatory and antioxidant effects via modulation of cytokine profiles and ROS scavenging, stimulation of cellular proliferation and migration (fibroblasts, keratinocytes), and positive influence on extracellular matrix (ECM) remodeling, potentially leading to reduced scar formation. Preclinical evidence consistently demonstrates accelerated wound closure, improved re-epithelialization, enhanced angiogenesis, and superior tissue quality in various animal models. However, substantial translational challenges remain regarding raw material standardization (CS molecular weight/deacetylation degree and AV acemannan quantification), residual crosslinker safety, and a lack of randomized clinical trials. This review critically balances the promising preclinical efficacy of CS–AV composites with the rigorous standardization, GLP toxicological profiling, and clinical frameworks required for bench-to-bedside translation.

Discover Materials
University of Mosul (IQ), Mashhad University of Medical Sciences (IR), University of Babylon (IQ), Taif University (SA), Iraqi University (IQ), Dr. D.Y. Patil Vidyapeeth, Pune (IN), Datta Meghe Institute of Higher Education and Research (IN), Dr D Y Patil Dental College & Hospital (IN), Mazaya University College (IQ), Batterjee Medical College (SA), Al-Zahrawi University (IQ), Islamic University of Najaf (IQ), Islamic University Babylon Campus (IQ), Nahrain University (IQ)
Good health and well-being
Openalex Percentile: Top 16%
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon